Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
81.96B | 77.99B | 77.30B | 73.42B | 74.19B | 68.05B | Gross Profit |
22.11B | 32.88B | 31.62B | 32.20B | 30.93B | 29.37B | EBIT |
17.49B | 17.01B | 15.93B | 15.22B | 14.45B | 13.97B | EBITDA |
23.86B | 23.48B | 22.11B | 22.17B | 21.42B | 20.28B | Net Income Common Stockholders |
12.03B | 12.13B | 10.85B | 10.66B | 10.52B | 9.87B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.09B | 3.16B | 3.26B | 3.19B | 3.10B | 3.37B | Total Assets |
113.53B | 115.57B | 119.65B | 118.61B | 112.18B | 105.67B | Total Debt |
12.00M | 43.00M | 106.00M | 198.00M | 308.00M | 419.00M | Net Debt |
-3.07B | -3.12B | -3.16B | -3.00B | -2.79B | -2.95B | Total Liabilities |
16.44B | 18.09B | 18.53B | 18.42B | 17.80B | 16.21B | Stockholders Equity |
94.52B | 95.09B | 98.88B | 96.42B | 91.03B | 86.51B |
Cash Flow | Free Cash Flow | ||||
7.74B | 1.76B | 6.66B | 10.49B | 9.57B | 3.38B | Operating Cash Flow |
14.28B | 11.33B | 14.64B | 18.77B | 19.07B | 14.87B | Investing Cash Flow |
-3.47B | 4.91B | -3.94B | -13.82B | -13.11B | -11.81B | Financing Cash Flow |
-11.11B | -16.35B | -10.63B | -4.85B | -6.24B | -3.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.44T | 20.02 | 3.91% | 7.57% | 6.30% | ||
80 Outperform | $13.51T | 13.25 | 9.84% | 3.18% | 2.47% | -20.86% | |
76 Outperform | ¥233.58B | 19.06 | 12.86% | 2.58% | 8.11% | 6.48% | |
73 Outperform | $510.62B | 25.18 | 14.78% | 1.18% | 14.76% | 0.69% | |
70 Outperform | ¥9.12T | 14.23 | 13.04% | 2.94% | 2.85% | 12.63% | |
66 Neutral | $372.75B | 28.01 | 15.57% | 1.13% | 6.94% | -14.06% | |
62 Neutral | $11.80B | 10.31 | -7.45% | 2.91% | 7.43% | -7.78% |